市場調查報告書
商品編碼
1466305
血型分型市場:按技術、測試、產品類型和最終用戶分類 - 2024-2030 年全球預測Blood Group Typing Market by Techniques (Assay-Based Techniques, Massively Parallel Sequencing, Microarray), Test Type (ABO Blood Tests, Antibody Screening, Antigen Typing), Product, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年血型分型市場規模預估為33.7億美元,預估2024年將達36.3億美元,2030年將達57.2億美元,複合年成長率為7.82%。
血型,也稱為血型或血液分類,是輸血醫學和移植的關鍵過程。辨識紅血球 (RBC) 表面的特定抗原、蛋白質和碳水化合物,以確定個人的血型。全球對安全輸血實踐的需求不斷成長是市場成長的關鍵因素之一。這項需求是由需要頻繁輸血的慢性疾病日益普及所推動的。然而,分子檢測等先進檢測技術的高成本限制了它們的採用,特別是在資源匱乏的環境中。缺乏能夠操作精密設備的熟練專業人員也是該行業面臨的重大挑戰。此外,政府改善衛生基礎設施的措施和私人組織增加投資將為市場參與企業創造機會。透過採用包括次世代定序(NGS) 在內的自動化技術,可以顯著提高吞吐量,同時減少測試過程中的人為錯誤。
主要市場統計 | |
---|---|
基準年[2023] | 33.7億美元 |
預計年份 [2024] | 36.3億美元 |
預測年份 [2030] | 57.2億美元 |
複合年成長率(%) | 7.82% |
技術:更多採用基於分析的大規模平行定序技術
基於測定的技術廣泛用於血型分型,可提供快速、準確的結果。使用血清學或分子技術,使用試劑來檢測紅血球表面的特定抗原。 MPS(大規模平行定序)或NGS(次世代定序)是一種可以同時分析多個基因組區域的先進技術。微陣列技術是基因組學研究中使用的一種高通量方法,可以同時分析各種基因和基因組區域。
測試類型用於檢測抗原的 ABO 血液測試和人類白血球抗原分型測試的迅速出現
ABO 血型測試是確定個人血型(A、B、AB、O)的最基本且廣泛使用的方法。這些測試可檢測紅血球上是否存在 A 和 B 抗原以及血漿中相應的抗體。抗體篩檢測試有助於識別血漿中臨床上重要的抗體,這些抗體可能在輸血和器官移植過程中引起副作用。抗原分型測試可確定紅血球上除 A 和 B 抗原外是否有特定抗原。進行交叉配血系列測試以直接確認供體和受體血液樣本的兼容性。人類白血球抗原 (HLA) 分型對於透過識別供體和受體之間匹配的 HLA 分子來確定器官移植的相容性至關重要。
產品:血型鑑定服務中耗材和儀器的關鍵使用
耗材是血型鑑定和區分各種血型所必需的材料。輸血、產前護理、器官移植和研究對準確、高效的血型檢測的需求正在推動對耗材的需求。血型分型中使用的設備包括分析儀、細胞分選儀、顯微鏡、離心機、液體處理機和移液器,這些設備能夠以高通量精確測量和分析樣品。服務包括為醫院、診斷中心、血庫和研究機構提供測試、諮詢、培訓和外包解決方案,以管理血型相關業務。
最終使用者:臨床實驗室和醫院血型服務的新用途
血庫在醫療產業中極為重要,因為它們收集、儲存血液和血液成分並將其分發給醫院和診所。臨床實驗室進行疾病檢測、監測、預防和治療策略的診斷測試。血型分型對於產前篩檢、器官移植適宜性評估和某些遺傳疾病的診斷至關重要。醫院主要需要輸血和器官移植的血型服務。
區域洞察
在美國和加拿大,由於先進的醫療基礎設施和巨大的輸血需求,血型鑑定的採用率顯著增加。最近,主要企業都投資了美國國立衛生研究院 (NIH) 資助的國家捐血者計畫等研究計畫。在加拿大,政府對醫療保健提供者的津貼增加正在推動對血型技術的需求。由於政府在醫療保健方面的支出增加和醫療技術的進步,亞太地區正在經歷顯著的成長。中國血型分型相關專利申請量快速增加,顯示研究和市場潛力。隨著日本人口老化和印度對血液相關疾病的認知不斷提高,對準確、高效的血型解決方案的需求日益成長。在歐洲,生物技術和生命科學領域的投資不斷增加,推動了市場成長。歐盟的地平線 2020 計畫透過其「邁向下一代健康資訊通訊技術」舉措,優先考慮個人化醫學研究。由於人口多樣化和健康差異,中東和非洲地區面臨獨特的挑戰。然而,人們越來越關注改善醫療保健的可近性,這為血型提供者創造了機會。
FPNV定位矩陣
FPNV定位矩陣對於評估血型分型市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對血型分型市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動和突破性產品開發的智力見解。
1.血型鑑定市場的市場規模與預測為何?
2.在血型分型市場的預測期內,我們應該考慮投資哪些產品和應用?
3.血型鑑定市場的技術趨勢和法規結構是什麼?
4.血型分型市場主要供應商的市場佔有率為何?
5.進入血型鑑定市場適合的型態和策略手段有哪些?
[193 Pages Report] The Blood Group Typing Market size was estimated at USD 3.37 billion in 2023 and expected to reach USD 3.63 billion in 2024, at a CAGR 7.82% to reach USD 5.72 billion by 2030.
Blood group typing, also known as blood typing or blood classification, is a crucial process in transfusion medicine and transplantation. It involves identifying specific antigens, proteins, and carbohydrates on the surface of red blood cells (RBCs) and determining an individual's blood group. The increasing demand for safe blood transfusion practices worldwide is one of the primary factors contributing to the market growth. This demand arises due to a growing prevalence of chronic diseases that require frequent blood transfusions. However, high costs associated with advanced testing techniques, such as molecular assays, limit their adoption, particularly in low-resource settings. A lack of skilled professionals capable of operating advanced instruments is another critical challenge th industry faces. Additionally, government initiatives improve healthcare infrastructure, and increased investment from private organizations presents opportunities for market players. Adopting automation technologies, including Next-Generation Sequencing (NGS), can significantly enhance throughput capabilities while reducing human errors during testing.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.37 billion |
Estimated Year [2024] | USD 3.63 billion |
Forecast Year [2030] | USD 5.72 billion |
CAGR (%) | 7.82% |
Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
Assay-based techniques are widely used for blood group typing, offering rapid and accurate results. They involve using reagents to detect specific antigens on red blood cells' surfaces using serological or molecular methods. Massively Parallel Sequencing (MPS), or Next-Generation Sequencing (NGS), is an advanced technique that allows simultaneous analysis of multiple genomic regions. Microarray technology is a high-throughput method utilized in genomics research that enables simultaneous analysis of various genes or genomic regions.
Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
ABO blood tests are the most basic and widely used method for identifying an individual's blood type (A, B, AB, or O). These tests detect the presence of A and B antigens on red blood cells and corresponding antibodies in plasma. Antibody screening tests help identify clinically significant antibodies in an individual's plasma that may cause adverse reactions during transfusions or organ transplants. Antigen typing tests determine the presence or absence of specific antigens on red blood cells beyond A and B antigens. Cross-matching series tests are performed to ensure donor and recipient blood samples' compatibility directly. Human leukocyte antigen (HLA) Typing is crucial for determining compatibility in organ transplantation by identifying matching HLA molecules between donors and recipients.
Product: Significant use of consumables and instruments in blood group typing services
Consumables are essential materials used in blood group typing to identify and differentiate the various blood groups. The need for consumables has increased due to the demand for accurate and efficient blood group testing for transfusions, prenatal care, organ transplants, and research. Instruments utilized in blood group typing involve devices such as analyzers, cell sorters, microscopes, centrifuges, liquid handlers, and pipettes that enable precise measurement and analysis of samples with high throughput capacity. Blood group typing services encompass testing, consulting, training, and outsourcing solutions that aid hospitals, diagnostic centers, blood banks, and research institutes in managing blood grouping-related activities.
End-User: Emerging use of blood group typing services in clinical laboratories and hospitals
Blood banks are crucial in the healthcare industry as they collect, store, and distribute blood and blood components to hospitals and clinics. Clinical laboratories conduct diagnostic tests for disease detection, monitoring, prevention, or treatment strategies. Blood group typing is essential for prenatal screening, organ transplantation compatibility assessment, or diagnosis of certain genetic conditions. Hospitals require blood group typing services primarily for transfusion purposes and organ transplantation procedures.
Regional Insights
In the Americas, the U.S. and Canada significantly increased the adoption of blood group typing owing to its advanced healthcare infrastructure and huge demand for blood transfusions. Key players have recently invested in research initiatives such as the NIH-funded National Blood Donor Project. In Canada, a rise in government funding for healthcare organizations is driving demand for blood group typing technologies. The Asia-Pacific region is encountering substantial growth due to increased government spending on healthcare and advancements in medical technologies. In China, patent filings related to blood group typing have surged, indicating strong research and market potential. Japan's aging population and India's rising awareness of blood-related disorders drive the need for accurate and efficient blood typing solutions. In Europe, growing investments in biotechnology and life sciences fuel market growth. The EU's Horizon 2020 program has prioritized personalized medicine research through initiatives 'Towards Next-Generation ICTs for Health.' The Middle East and Africa region face unique challenges from their diverse populations and health disparities. However, an increasing focus on improving healthcare access creates opportunities for blood group typing providers.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Blood Group Typing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Group Typing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Blood Group Typing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Group Typing Market?
3. What are the technology trends and regulatory frameworks in the Blood Group Typing Market?
4. What is the market share of the leading vendors in the Blood Group Typing Market?
5. Which modes and strategic moves are suitable for entering the Blood Group Typing Market?